Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis

NCT01457924

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • GSK Investigational Site Cullman, Alabama, United States
  • GSK Investigational Site Fullerton, California, United States
  • GSK Investigational Site Fairfield, Connecticut, United States
  • GSK Investigational Site Miami, Florida, United States
View all 61 locations
View Trial Details
Completed

Ireland Natalizumab (TYSABRI) Observational Program

NCT01943526

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research site Cork, County Cork, Ireland
  • Research site Dublin, County Dublin, Ireland
  • Research site Galway, County Galway, Ireland
  • Research site Tralee, County Kerry, Ireland
View Trial Details
Completed

Long-term Safety, Tolerability and Efficacy of BAF312 Given Orally in Patients With Relapsing-remitting Multiple Sclerosis

NCT01185821

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Miami, Florida, United States
  • Novartis Investigative Site Pompano Beach, Florida, United States
  • Novartis Investigative Site Tallahassee, Florida, United States
  • Novartis Investigative Site Chicago, Illinois, United States
View all 46 locations
View Trial Details
Completed

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

NCT02823951

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Alabama Neurology Associates Birmingham, Alabama, United States
  • Colorado Springs Neurological Associates Colorado Springs, Colorado, United States
  • Savannah Neurology Specialists Savannah, Georgia, United States
  • Northshore University Evanston, Illinois, United States
View all 23 locations
View Trial Details

Related conditions